Bruce Goodwin: Sitting on the sidelines not an option

December 6, 2016 BioPharmaDispatch Executive

This is a preview of subscriber content

Subscribe now to continue reading.

"The long-term fiscal challenge facing government is clearly the number one issue facing all health stakeholders, including industry," says Janssen's Bruce Goodwin. …

Subscribe now to continue reading.

Latest Video

New Stories

Australia’s life sciences sector emerges as fast growing, globally connected powerhouse
May 21, 2026 - - Latest News
They used to forecast growth, it was not real and couldn't be used, and it made the program a target for cuts
May 21, 2026 - - Latest News
New report reveals how AI is now deciding which healthcare brands Australians see online
May 21, 2026 - - Latest News
Medicine shortages and workforce gaps threaten the sustainability of Australian care
May 21, 2026 - - Latest News
Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS
May 20, 2026 - - Latest News
Owen Smith: 'We are ready to negotiate. We are ready to be a genuine partner'
May 19, 2026 - - Latest News
Australia bets on translational science to turn discovery into global impact
May 19, 2026 - - Latest News

Bruce Goodwin: Sitting on the sidelines not an option

This is a preview of subscriber content

Latest Video

Most Read

New partnership expands access to care for Australians with rare cancers

Sandoz urges faster access as government signals biosimilar consultation

Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS

Owen Smith: 'We are ready to negotiate. We are ready to be a genuine partner'

Perth hosts AusMedtech conference as industry focuses on innovation and commercialisation

New Stories

Australia’s life sciences sector emerges as fast growing, globally connected powerhouse

They used to forecast growth, it was not real and couldn't be used, and it made the program a target for cuts

New report reveals how AI is now deciding which healthcare brands Australians see online

Medicine shortages and workforce gaps threaten the sustainability of Australian care

Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS

Owen Smith: 'We are ready to negotiate. We are ready to be a genuine partner'

Australia bets on translational science to turn discovery into global impact

Sign In

Bruce Goodwin: Sitting on the sidelines not an option

This is a preview of subscriber content

Latest Video

Most Read

New partnership expands access to care for Australians with rare cancers

Sandoz urges faster access as government signals biosimilar consultation

Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS

Owen Smith: 'We are ready to negotiate. We are ready to be a genuine partner'

Perth hosts AusMedtech conference as industry focuses on innovation and commercialisation

Follow Us

New Stories

Australia’s life sciences sector emerges as fast growing, globally connected powerhouse

They used to forecast growth, it was not real and couldn't be used, and it made the program a target for cuts

New report reveals how AI is now deciding which healthcare brands Australians see online

Medicine shortages and workforce gaps threaten the sustainability of Australian care

Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS

Owen Smith: 'We are ready to negotiate. We are ready to be a genuine partner'

Australia bets on translational science to turn discovery into global impact